Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone

Laura A. Napolitano, Joan C. Lo, Michael Gotway, Kathleen Mulligan, Jason D. Barbour, Diane Schmidt, Robert M. Grant, Robert A. Halvorsen, Morris Schambelan, Joseph M. McCune

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Objective: To determine whether treatment with growth hormone (GH) enhances thymopoiesis in individuals infected with HIV-1. Methods: Five HIV-1-infected adults were treated with GH for 6-12 months in a prospective open-label study. Immunological analyses were performed before GH treatment and repeated at 3 month intervals after GH initiation. Thymic mass was analysed using computed tomography with quantitative density and volume analysis. Analysis of circulating lymphocytes, including naive and memory T cell subsets, was performed using multiparameter flow cytometry. Results: GH treatment was associated with a marked increase in thymic mass in all GH recipients. Circulating naive CD4 T cells also increased significantly in all patients during GH therapy, suggesting an enhancement of thymopoiesis. Conclusion: GH has significant effects on the human immune system, including the reversal of thymic atrophy in HIV-1-infected adults. De-novo T cell production may thus be inducible in immunodeficient adults.

Original languageEnglish (US)
Pages (from-to)1103-1111
Number of pages9
JournalAIDS
Volume16
Issue number8
DOIs
StatePublished - May 24 2002
Externally publishedYes

Fingerprint

Growth Hormone
HIV-1
T-Lymphocytes
T-Lymphocyte Subsets
Therapeutics
Atrophy
Immune System
Flow Cytometry
Tomography
Lymphocytes

Keywords

  • AIDS
  • CD4 T cells
  • Growth hormone
  • Immune reconstitution
  • Immune-based therapy
  • Thymus

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Napolitano, L. A., Lo, J. C., Gotway, M., Mulligan, K., Barbour, J. D., Schmidt, D., ... McCune, J. M. (2002). Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS, 16(8), 1103-1111. https://doi.org/10.1097/00002030-200205240-00003

Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. / Napolitano, Laura A.; Lo, Joan C.; Gotway, Michael; Mulligan, Kathleen; Barbour, Jason D.; Schmidt, Diane; Grant, Robert M.; Halvorsen, Robert A.; Schambelan, Morris; McCune, Joseph M.

In: AIDS, Vol. 16, No. 8, 24.05.2002, p. 1103-1111.

Research output: Contribution to journalArticle

Napolitano, LA, Lo, JC, Gotway, M, Mulligan, K, Barbour, JD, Schmidt, D, Grant, RM, Halvorsen, RA, Schambelan, M & McCune, JM 2002, 'Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone', AIDS, vol. 16, no. 8, pp. 1103-1111. https://doi.org/10.1097/00002030-200205240-00003
Napolitano, Laura A. ; Lo, Joan C. ; Gotway, Michael ; Mulligan, Kathleen ; Barbour, Jason D. ; Schmidt, Diane ; Grant, Robert M. ; Halvorsen, Robert A. ; Schambelan, Morris ; McCune, Joseph M. / Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. In: AIDS. 2002 ; Vol. 16, No. 8. pp. 1103-1111.
@article{51e8043fca8a4e7ebd3bf5e70e00d50b,
title = "Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone",
abstract = "Objective: To determine whether treatment with growth hormone (GH) enhances thymopoiesis in individuals infected with HIV-1. Methods: Five HIV-1-infected adults were treated with GH for 6-12 months in a prospective open-label study. Immunological analyses were performed before GH treatment and repeated at 3 month intervals after GH initiation. Thymic mass was analysed using computed tomography with quantitative density and volume analysis. Analysis of circulating lymphocytes, including naive and memory T cell subsets, was performed using multiparameter flow cytometry. Results: GH treatment was associated with a marked increase in thymic mass in all GH recipients. Circulating naive CD4 T cells also increased significantly in all patients during GH therapy, suggesting an enhancement of thymopoiesis. Conclusion: GH has significant effects on the human immune system, including the reversal of thymic atrophy in HIV-1-infected adults. De-novo T cell production may thus be inducible in immunodeficient adults.",
keywords = "AIDS, CD4 T cells, Growth hormone, Immune reconstitution, Immune-based therapy, Thymus",
author = "Napolitano, {Laura A.} and Lo, {Joan C.} and Michael Gotway and Kathleen Mulligan and Barbour, {Jason D.} and Diane Schmidt and Grant, {Robert M.} and Halvorsen, {Robert A.} and Morris Schambelan and McCune, {Joseph M.}",
year = "2002",
month = "5",
day = "24",
doi = "10.1097/00002030-200205240-00003",
language = "English (US)",
volume = "16",
pages = "1103--1111",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone

AU - Napolitano, Laura A.

AU - Lo, Joan C.

AU - Gotway, Michael

AU - Mulligan, Kathleen

AU - Barbour, Jason D.

AU - Schmidt, Diane

AU - Grant, Robert M.

AU - Halvorsen, Robert A.

AU - Schambelan, Morris

AU - McCune, Joseph M.

PY - 2002/5/24

Y1 - 2002/5/24

N2 - Objective: To determine whether treatment with growth hormone (GH) enhances thymopoiesis in individuals infected with HIV-1. Methods: Five HIV-1-infected adults were treated with GH for 6-12 months in a prospective open-label study. Immunological analyses were performed before GH treatment and repeated at 3 month intervals after GH initiation. Thymic mass was analysed using computed tomography with quantitative density and volume analysis. Analysis of circulating lymphocytes, including naive and memory T cell subsets, was performed using multiparameter flow cytometry. Results: GH treatment was associated with a marked increase in thymic mass in all GH recipients. Circulating naive CD4 T cells also increased significantly in all patients during GH therapy, suggesting an enhancement of thymopoiesis. Conclusion: GH has significant effects on the human immune system, including the reversal of thymic atrophy in HIV-1-infected adults. De-novo T cell production may thus be inducible in immunodeficient adults.

AB - Objective: To determine whether treatment with growth hormone (GH) enhances thymopoiesis in individuals infected with HIV-1. Methods: Five HIV-1-infected adults were treated with GH for 6-12 months in a prospective open-label study. Immunological analyses were performed before GH treatment and repeated at 3 month intervals after GH initiation. Thymic mass was analysed using computed tomography with quantitative density and volume analysis. Analysis of circulating lymphocytes, including naive and memory T cell subsets, was performed using multiparameter flow cytometry. Results: GH treatment was associated with a marked increase in thymic mass in all GH recipients. Circulating naive CD4 T cells also increased significantly in all patients during GH therapy, suggesting an enhancement of thymopoiesis. Conclusion: GH has significant effects on the human immune system, including the reversal of thymic atrophy in HIV-1-infected adults. De-novo T cell production may thus be inducible in immunodeficient adults.

KW - AIDS

KW - CD4 T cells

KW - Growth hormone

KW - Immune reconstitution

KW - Immune-based therapy

KW - Thymus

UR - http://www.scopus.com/inward/record.url?scp=0037165910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037165910&partnerID=8YFLogxK

U2 - 10.1097/00002030-200205240-00003

DO - 10.1097/00002030-200205240-00003

M3 - Article

C2 - 12004268

AN - SCOPUS:0037165910

VL - 16

SP - 1103

EP - 1111

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 8

ER -